Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.
Blotting-Western, Bone-Density: ph, Bone-Marrow-Cells: cy, Cell-Division: ph, Coculture, Dentin: pa, Femur: ra, pa, Homozygote, In-Vitro, Mice, Mice-Inbred-C57BL, Mice-Mutant-Strains, Mutation: ph, Osteoblasts: cy, Osteoclasts: ph, pa, Protein-Tyrosine-Phosphatase: ge, df, SUPPORT-U-S-GOVT-P-H-S, Tomography
Am J Pathol 1999 Jul;155(1):223-33
CA20408/CA/NCI, AR43618/AR/NIAMS, CA79891/CA/NCI
Mice homozygous for the motheaten (Hcphme) or viable motheaten (Hcphme-v) mutations are deficient in functional SHP-1 protein-tyrosine phosphatase and show severe defects in hematopoiesis. Comparison of femurs from mev/mev mice revealed significant decreases in bone mineral density (0.33 +/- 0.03 mg/mm3 for mev/mevversus 0.41 +/- 0.01 mg/mm3 for controls) and mineral content (1.97 +/- 0.36 mg for mev/mevversus 10.64 +/- 0.67 for controls) compared with littermate controls. Viable motheaten mice also showed reduced amounts of trabecular bone and decreased cortical thickness. These bone abnormalities were associated with a 14% increase in numbers of multinucleated osteoclasts and an increase in osteoclast resorption activity. In co-cultures of normal osteoblasts with mutant or control bone marrow cells, numbers of osteoclasts developing from mutant mice were increased compared with littermate control mice. Although mev/mev osteoclasts develop in the absence of colony-stimulating factor (CSF)-1, nevertheless cultured osteoclasts show increased size in the presence of CSF-1. CSF-1-deficient osteopetrosis (op/op) mutant mice develop severe osteosclerosis. However, doubly homozygous mev/mevop/op mice show an expansion of bone marrow cavities and reduced trabecular bone mass compared with op/op mice. Western blot analysis showed that several proteins that were markedly hyperphosphorylated on tyrosine residues were detected in the motheaten osteoclasts, including a novel 126-kd phosphotyrosine protein. The marked hyperphosphorylation of a 126-kd protein in motheaten osteoclasts suggests that this protein depends on SHP-1 for dephosphorylation. These findings demonstrate that the decreased SHP-1 catalytic activity in me/me and mev/mev mice results in an increased population of activated osteoclasts and consequent reduction in bone density.
Umeda, S; Beamer, W G.; Takagi, K; Naito, M; Hayashi, S; Yonemitsu, H; Yi, T; and Shultz, L D., " Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density." (1999). Faculty Research 1990 - 1999. 1263.
Please contact the Joan Staats Library for information regarding this document.